Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (141-150 of 450) with videos related to

Pageof 45
Sort By:
Arzneimittel-Forschung|May 27, 2006
Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonistD Jeremy Stewart, Hesham Fahmy, Bryan L Roth, et al.
Nature Structural & Molecular Biology|April 20, 2026
Structural insights into coffee bitter taste perception by TAS2R43 receptorYoojoong Kim, Ryan H Gumpper, Yuxuan Zhuang, et al.
Journal of Medicinal Chemistry|January 19, 2008
Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studiesMałgorzata Dukat, Philip D Mosier, Renata Kolanos, et al.
Pharmacology & Therapeutics|May 28, 2004
Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discoveryBryan L Roth, Estela Lopez, Scott Beischel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandBlaine N Armbruster, Xiang Li, Mark H Pausch, et al.
American Journal of Physiology. Cell Physiology|June 25, 2010
RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signalingGeneviève Laroche, Patrick M Giguère, Bryan L Roth, et al.
Nature|February 22, 2018
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidoneSheng Wang, Tao Che, Anat Levit, et al.
Journal of Medicinal Chemistry|January 22, 2005
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonistThomas A Munro, Mark A Rizzacasa, Bryan L Roth, et al.
The Journal of Biological Chemistry|January 22, 2002
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6David A Shapiro, Kurt Kristiansen, David M Weiner, et al.
European Journal of Pharmacology|December 25, 2012
Neurochemical profiles of some novel psychoactive substancesLes Iversen, Simon Gibbons, Ric Treble, et al.
Pageof 45

Showing results (141-150 of 450) with videos related to

Sort By:
Pageof 45
Arzneimittel-Forschung|May 27, 2006
Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonistD Jeremy Stewart, Hesham Fahmy, Bryan L Roth, et al.
Nature Structural & Molecular Biology|April 20, 2026
Structural insights into coffee bitter taste perception by TAS2R43 receptorYoojoong Kim, Ryan H Gumpper, Yuxuan Zhuang, et al.
Journal of Medicinal Chemistry|January 19, 2008
Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studiesMałgorzata Dukat, Philip D Mosier, Renata Kolanos, et al.
Pharmacology & Therapeutics|May 28, 2004
Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discoveryBryan L Roth, Estela Lopez, Scott Beischel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandBlaine N Armbruster, Xiang Li, Mark H Pausch, et al.
American Journal of Physiology. Cell Physiology|June 25, 2010
RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signalingGeneviève Laroche, Patrick M Giguère, Bryan L Roth, et al.
Nature|February 22, 2018
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidoneSheng Wang, Tao Che, Anat Levit, et al.
Journal of Medicinal Chemistry|January 22, 2005
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonistThomas A Munro, Mark A Rizzacasa, Bryan L Roth, et al.
The Journal of Biological Chemistry|January 22, 2002
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6David A Shapiro, Kurt Kristiansen, David M Weiner, et al.
European Journal of Pharmacology|December 25, 2012
Neurochemical profiles of some novel psychoactive substancesLes Iversen, Simon Gibbons, Ric Treble, et al.
Pageof 45